These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 8621535

  • 21. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets.
    Yin K, Halushka PV, Yan YT, Wong PY.
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1192-6. PubMed ID: 7932171
    [Abstract] [Full Text] [Related]

  • 22. Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture.
    Bishop-Bailey D, Larkin SW, Warner TD, Chen G, Mitchell JA.
    Br J Pharmacol; 1997 May; 121(1):125-33. PubMed ID: 9146896
    [Abstract] [Full Text] [Related]

  • 23. Contribution of cyclooxygenase-1 and cyclooxygenase-2 to prostanoid formation by human enterocytes stimulated by calcium ionophore and inflammatory agents.
    Longo WE, Panesar N, Mazuski J, Kaminski DL.
    Prostaglandins Other Lipid Mediat; 1998 Aug; 56(5-6):325-39. PubMed ID: 9990676
    [Abstract] [Full Text] [Related]

  • 24. Polyunsaturated fatty acids and bovine interferon-tau modify phorbol ester-induced secretion of prostaglandin F2 alpha and expression of prostaglandin endoperoxide synthase-2 and phospholipase-A2 in bovine endometrial cells.
    Mattos R, Guzeloglu A, Badinga L, Staples CR, Thatcher WW.
    Biol Reprod; 2003 Sep; 69(3):780-7. PubMed ID: 12724278
    [Abstract] [Full Text] [Related]

  • 25. Formation of an F2-isoprostane in vascular smooth muscle cells by elevated glucose and growth factors.
    Natarajan R, Lanting L, Gonzales N, Nadler J.
    Am J Physiol; 1996 Jul; 271(1 Pt 2):H159-65. PubMed ID: 8760171
    [Abstract] [Full Text] [Related]

  • 26. Isoprostanes and PGE2 production in human isolated pulmonary artery smooth muscle cells: concomitant and differential release.
    Jourdan KB, Evans TW, Goldstraw P, Mitchell JA.
    FASEB J; 1999 Jun; 13(9):1025-30. PubMed ID: 10336884
    [Abstract] [Full Text] [Related]

  • 27. Vasoconstrictor effects of iso-prostaglandin F2alpha type-III (8-iso-prostaglandin F2alpha) on human saphenous veins.
    Gardan B, Cracowski JL, Sessa C, Hunt M, Stanke-Labesque F, Devillier P, Bessard G.
    J Cardiovasc Pharmacol; 2000 May; 35(5):729-34. PubMed ID: 10813374
    [Abstract] [Full Text] [Related]

  • 28. Evidence that the F2-isoprostane, 8-epi-prostaglandin F2 alpha, is formed in vivo.
    Morrow JD, Minton TA, Badr KF, Roberts LJ.
    Biochim Biophys Acta; 1994 Jan 03; 1210(2):244-8. PubMed ID: 8280777
    [Abstract] [Full Text] [Related]

  • 29. Pharmacological manipulation of cyclo-oxygenase-2 in the inflamed hydronephrotic kidney.
    Seibert K, Masferrer JL, Needleman P, Salvemini D.
    Br J Pharmacol; 1996 Mar 03; 117(6):1016-20. PubMed ID: 8882591
    [Abstract] [Full Text] [Related]

  • 30. Stimulation of prostaglandin synthesis in cultured liver cells by CCl4.
    Johnston DE, Kroening C.
    Hepatology; 1996 Sep 03; 24(3):677-84. PubMed ID: 8781342
    [Abstract] [Full Text] [Related]

  • 31. Prostaglandin and thromboxane biosynthesis.
    Smith WL, Marnett LJ, DeWitt DL.
    Pharmacol Ther; 1991 Sep 03; 49(3):153-79. PubMed ID: 1905023
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Differential regulation of prostaglandin E2 and thromboxane A2 production in human monocytes: implications for the use of cyclooxygenase inhibitors.
    Penglis PS, Cleland LG, Demasi M, Caughey GE, James MJ.
    J Immunol; 2000 Aug 01; 165(3):1605-11. PubMed ID: 10903770
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Evidence for a dilator function of 8-iso prostaglandin F2 alpha in rat pulmonary artery.
    Jourdan KB, Evans TW, Curzen NP, Mitchell JA.
    Br J Pharmacol; 1997 Apr 01; 120(7):1280-5. PubMed ID: 9105703
    [Abstract] [Full Text] [Related]

  • 36. Characterization of signal transduction events stimulated by 8-epi-prostaglandin(PG)F2 alpha in rat aortic rings.
    Wagner RS, Weare C, Jin N, Mohler ER, Rhoades RA.
    Prostaglandins; 1997 Aug 01; 54(2):581-99. PubMed ID: 9380800
    [Abstract] [Full Text] [Related]

  • 37. Formation of 8-iso-prostaglandin F2 alpha by human platelets.
    Pratico D, Reilly M, Lawson J, Delanty N, FitzGerald GA.
    Agents Actions Suppl; 1995 Aug 01; 45():27-31. PubMed ID: 7717189
    [Abstract] [Full Text] [Related]

  • 38. Isoprostane 8-epi-prostaglandin F2 alpha is a potent contractor of human peripheral lymphatics.
    Sinzinger H, Oguogho A, Kaliman J.
    Lymphology; 1997 Sep 01; 30(3):155-9. PubMed ID: 9313207
    [Abstract] [Full Text] [Related]

  • 39. Regulation of cyclooxygenase and thromboxane synthase in human monocytes.
    Nüsing R, Ullrich V.
    Eur J Biochem; 1992 May 15; 206(1):131-6. PubMed ID: 1587265
    [Abstract] [Full Text] [Related]

  • 40. IPF2alpha-I: an index of lipid peroxidation in humans.
    Praticò D, Barry OP, Lawson JA, Adiyaman M, Hwang SW, Khanapure SP, Iuliano L, Rokach J, FitzGerald GA.
    Proc Natl Acad Sci U S A; 1998 Mar 31; 95(7):3449-54. PubMed ID: 9520386
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.